65 Therapeutics, Inc. — Form D/A
65 Therapeutics, Inc. of SOMERVILLE, MA, a company, filed a Form D amendment with the SEC on 2026-07-06. The offering totals $6.7M, of which $6.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2026-07-06
- Form: D/A
- Accession: 0002047647-26-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.7M
- Amount sold: $6.7M
- Investors: 2
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-531309
Issuer
- Name: 65 Therapeutics, Inc.
- CIK: 0002047647
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 399 REVOLUTION DRIVE 399 Revolution Drive, SOMERVILLE, MA, 02145
- Phone: 617-784-9147
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Murthy Chavali | Related Person | Somerville, MA |
| Julius Knowles | Related Person | Somerville, MA |
| Murthy Chavali | Director | Somerville, MA |
| Julius Knowles | Director | Somerville, MA |
| Julius Knowles | Executive Officer | Somerville, MA |
Other filings by this issuer (1)
More